Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy

This publication has 26 references indexed in Scilit:

• Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Radiotherapy with a Radiolabeled Somatostatin Analogue, [¹¹¹In‐DTPA‐d‐Phe¹]‐Octreotide
  Annals of the New York Academy of Sciences, 1994
• Biological effectiveness of 67-gallium decay in HL60 cells compared with external low dose rate gamma irradiation: Effects on proliferation, G2 arrest, and clonogenic capacity
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Iodine-123 labelling of atrial natriuretic peptide and its analogues: initial results
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Radionuclide therapy revisited
  European Journal of Nuclear Medicine and Molecular Imaging, 1991
• The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex
  Journal of the American Chemical Society, 1988
• New specific radioligand for one subpopulation of brain somatostatin receptors
  Life Sciences, 1985
• Radionuclide diagnosis and therapy of thyroid cancer: Current status report
  Seminars in Nuclear Medicine, 1985